Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Medicare Drug Price Negotiation

Medicare negotiated drug prices

The first 10 negotiated prices took effect on January 1, 2026. Fifteen more start January 1, 2027, and another 15 - including the first Part B drugs - in 2028. Here is every drug, its list price and its negotiated "maximum fair price", and what it means for what you pay.

2026: 10 drugs (in effect)

DrugTreatsList priceNegotiatedCut
Januvia sitagliptinType 2 diabetes$527.00$113.00-79%
NovoLog / Fiasp insulin aspartDiabetes$495.00$119.00-76%
Farxiga dapagliflozinType 2 diabetes, heart failure, kidney disease$556.00$178.50-68%
Enbrel etanerceptRheumatoid arthritis, psoriasis, psoriatic arthritis$7,106.00$2,355.00-67%
Jardiance empagliflozinType 2 diabetes, heart failure, kidney disease$573.00$197.00-66%
Stelara ustekinumabPsoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis$13,836.00$4,695.00-66%
Xarelto rivaroxabanBlood clots, stroke prevention (AFib)$517.00$197.00-62%
Eliquis apixabanBlood clots, stroke prevention (AFib)$521.00$231.00-56%
Entresto sacubitril / valsartanHeart failure$628.00$295.00-53%
Imbruvica ibrutinibBlood cancers$14,934.00$9,319.00-38%

Prices for a 30-day supply. List prices are from 2023.

2027: 15 drugs (from January 1, 2027)

DrugTreatsList priceNegotiatedCut
Janumet / Janumet XR sitagliptin / metforminType 2 diabetes$526.00$80.00-85%
Tradjenta linagliptinType 2 diabetes$488.00$78.00-84%
Breo Ellipta fluticasone furoate / vilanterolCOPD, asthma$397.00$67.00-83%
Linzess linaclotideIrritable bowel syndrome with constipation, chronic constipation$539.00$136.00-75%
Trelegy Ellipta fluticasone furoate / umeclidinium / vilanterolCOPD, asthma$654.00$175.00-73%
Ozempic / Rybelsus / Wegovy semaglutideType 2 diabetes, weight management, cardiovascular risk$959.00$274.00-71%
Otezla apremilastPsoriasis, psoriatic arthritis, Behcet's disease$4,722.00$1,650.00-65%
Xifaxan rifaximinIrritable bowel syndrome with diarrhea, hepatic encephalopathy$2,696.00$1,000.00-63%
Pomalyst pomalidomideMultiple myeloma, Kaposi sarcoma$21,744.00$8,650.00-60%
Ibrance palbociclibBreast cancer$15,741.00$7,871.00-50%
Ofev nintedanibIdiopathic pulmonary fibrosis$12,622.00$6,350.00-50%
Xtandi enzalutamideProstate cancer$13,480.00$7,004.00-48%
Vraylar cariprazineSchizophrenia, bipolar disorder, depression$1,376.00$770.00-44%
Calquence acalabrutinibBlood cancers$14,228.00$8,600.00-40%
Austedo / Austedo XR deutetrabenazineChorea (Huntington's disease), tardive dyskinesia$6,623.00$4,093.00-38%

Prices for a 30-day supply. List prices are from 2024.

2028: 15 drugs (from January 1, 2028)

DrugTreatsPrice
Anoro Ellipta umeclidinium / vilanterolCOPDPublished by Nov 30, 2026
Biktarvy bictegravir / emtricitabine / tenofovir alafenamideHIVPublished by Nov 30, 2026
Botox onabotulinumtoxinA · Part BMigraine, overactive bladder, spasticity and morePublished by Nov 30, 2026
Cimzia certolizumab pegol · Part BCrohn's disease, rheumatoid arthritis, psoriatic arthritisPublished by Nov 30, 2026
Cosentyx secukinumabPsoriasis, psoriatic arthritis, ankylosing spondylitisPublished by Nov 30, 2026
Entyvio vedolizumab · Part BUlcerative colitis, Crohn's diseasePublished by Nov 30, 2026
Erleada apalutamideProstate cancerPublished by Nov 30, 2026
Kisqali ribociclibBreast cancerPublished by Nov 30, 2026
Lenvima lenvatinibThyroid, kidney, liver and endometrial cancersPublished by Nov 30, 2026
Orencia abatacept · Part BRheumatoid arthritis, psoriatic arthritisPublished by Nov 30, 2026
Rexulti brexpiprazoleDepression, schizophrenia, Alzheimer's agitationPublished by Nov 30, 2026
Trulicity dulaglutideType 2 diabetesPublished by Nov 30, 2026
Verzenio abemaciclibBreast cancerPublished by Nov 30, 2026
Xeljanz tofacitinibRheumatoid arthritis, psoriatic arthritis, ulcerative colitisPublished by Nov 30, 2026
Xolair omalizumab · Part BAsthma, chronic hives, food allergy, nasal polypsPublished by Nov 30, 2026

What it means for what you pay

  • The negotiated price is what Medicare drug plans pay. Your cost at the counter depends on your plan's copay or coinsurance, not on the list price alone.
  • With coinsurance (a percentage), a lower price lowers your cost directly. With a flat copay, it may not change.
  • Part D out-of-pocket costs are capped at $2,100 in 2026, so people who reach the cap already pay nothing more that year.
  • The negotiated prices apply to Medicare only - not to private insurance or cash prices.

How the negotiation works

  • Medicare picks high-spending drugs with no generic or biosimilar competition, years after approval.
  • It negotiates a "maximum fair price" with the maker; the price takes effect about 14 months later.
  • Up to 15 drugs are added for 2027 and 2028, and up to 20 a year after that.
  • A drug leaves the program once a generic or biosimilar comes to market.

Questions about Medicare's negotiated prices

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Get drug price alerts

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.